We are live on ! Find out more
CANO

Cano Health, Inc.

Delisted

CANO was delisted on the 2nd of February, 2024.

145 hedge funds and large institutions have $726M invested in Cano Health, Inc. in 2022 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 43 increasing their positions, 45 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

410% more call options, than puts

Call options by funds: $6.91M | Put options by funds: $1.35M

0% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 34

1% less funds holding

Funds holding: 146145 (-1)

4% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 45

26% less capital invested

Capital invested by funds: $980M → $726M (-$254M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
145
Holders Change
-1
Holders Change %
-0.68%
% of All Funds
2.44%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
34
Increased
43
Reduced
45
Closed
34
Calls
$6.91M
Puts
$1.35M
Net Calls
+$5.55M
Net Calls Change
-$13.3M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$136M +$5.99M +11,484 +4%
JP Morgan Chase
2
JP Morgan Chase
New York
$70.8M +$32.3M +61,860 +62%
Vanguard Group
3
Vanguard Group
Pennsylvania
$69.4M +$16.2M +31,055 +24%
BlackRock
4
BlackRock
New York
$56.7M +$38.9M +74,500 +136%
TP
5
Third Point
New York
$47.4M -$3.52M -6,750 -6%
SC
6
Samlyn Capital
New York
$43.8M +$21.7M +41,585 +71%
OCAM
7
Owl Creek Asset Management
New York
$37.5M +$5.14M +9,854 +13%
MC
8
Maverick Capital
Texas
$36.6M
Citadel Advisors
9
Citadel Advisors
Florida
$27.8M +$6.77M +12,982 +26%
Goldman Sachs
10
Goldman Sachs
New York
$24.1M +$16.4M +31,500 +134%
EHI
11
Eagle Health Investments
Connecticut
$16.7M +$4.49M +8,616 +29%
State Street
12
State Street
Massachusetts
$14.7M +$12M +22,933 +215%
Millennium Management
13
Millennium Management
New York
$13.2M -$16.9M -32,453 -52%
CCM
14
Camber Capital Management
Massachusetts
$13.1M +$15.6M +30,000 New
Geode Capital Management
15
Geode Capital Management
Massachusetts
$13M +$7.48M +14,339 +93%
Barclays
16
Barclays
United Kingdom
$7.39M -$3.49M -6,693 -28%
Northern Trust
17
Northern Trust
Illinois
$6.7M +$5.96M +11,421 +295%
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$6.45M -$2.7M -5,175 -26%
Wellington Management Group
19
Wellington Management Group
Massachusetts
$6.38M -$16.9M -32,446 -69%
AWG
20
Alpha Wave Global
New York
$6.33M
Charles Schwab
21
Charles Schwab
California
$5.67M +$2M +3,841 +42%
Morgan Stanley
22
Morgan Stanley
New York
$3.48M -$138K -265 -3%
PFS
23
Prospera Financial Services
Texas
$3.36M +$1.18M +2,272 +42%
Balyasny Asset Management
24
Balyasny Asset Management
Illinois
$3.07M -$1.33M -2,557 -27%
ECM
25
Engle Capital Management
Connecticut
$2.81M +$3.34M +6,411 New

CANO Hedge Fund Activity: Q2 2022 in Review

145 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Cano Health, Inc. (CANO) for Q2 2022, worth a combined $726M — down 26% from $980M a quarter earlier.

Fund positioning in CANO was balanced in Q2 2022: 34 funds opened new positions, 34 closed out, 43 added to existing stakes and 45 trimmed.

The largest buyer was BlackRock, adding an estimated $38.9M. The largest seller was ArrowMark Colorado Holdings, exiting entirely with an estimated $28.5M sold.

  • 145 institutional investors held Cano Health, Inc. (CANO) as of Q2 2022, down from 146 in Q1 2022.
  • Funds reported $726M of Cano Health, Inc. stock for Q2 2022, down 26% quarter-over-quarter.
  • 34 funds opened new Cano Health, Inc. positions in Q2 2022 and 34 closed out, a net change of 0 holders.
  • The largest Cano Health, Inc. buyer in Q2 2022 was BlackRock, an estimated $38.9M added.
  • The largest Cano Health, Inc. seller in Q2 2022 was ArrowMark Colorado Holdings, an estimated $28.5M sold.

Based on aggregated 13F filings for Q2 2022.